Clinical Trials on AMS in United Kingdom

Total 712 results

Astellas Pharma Global Development, Inc.

No longer available

Early Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or With FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)

Acute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) Mutations

Australia, Italy, United Kingdom
Oraya Therapeutics, Inc.

Withdrawn

Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

Macular Degeneration | Age-related Macular Degeneration | AMD | Wet AMD | Wet Age-related Macular Degeneration

United Kingdom, Italy
Moorfields Eye Hospital NHS Foundation Trust
King's College London; Cardiff University; University College, London; Newcastle... and other collaborators

Recruiting

Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners (FENETRE)

AMD

United Kingdom
Clavis Pharma
Syneos Health; Theradex; CardiaBase; Learn & Confirm

Completed

The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)

Relapsed/Refractory AML

United Kingdom, Spain
Weill Medical College of Cornell University
Sidney R. Baer, Jr. Foundation

Completed

Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk

Prodromal Symptoms | ARMS | APS

United States
Amrit Sinha
National Health Service, United Kingdom

Unknown

Does Five Session CAT Consultancy Lead to Improved Outcomes?

Treatment as Usual | Psychological Intervention

United Kingdom
Nottinghamshire Healthcare NHS Trust
University of Nottingham; University of Southampton; University of Leicester; Institute...

Terminated

Individual Placement and Support for Patients With Offending Histories (IPSOH)

Treatment as Usual | Employment, Supported

United Kingdom
Imperial College London
Joint Replacement Instrumented Orthopaedics Ltd

Recruiting

Furlong Evolution® Hip Trial

Focus: A Multicentre Prospective Clinical Surveillance Study Aims to Assess the Clinical, Functional and Radiological Outcome of the Furlong Evolution® Hip Stem

United Kingdom
Alder Hey Children's NHS Foundation Trust

Completed

The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19 (LAVA)

Covid19 | This is a Pilot Study Which Aims to Assess the Validity and Applicability of Lateral Flow Assays (LFAs) Which Can be Used as a Point of Care Test for COVID-19

United Kingdom
Clinuvel (UK) Ltd.

Completed

DNA Repair Capacity of Afamelanotide on Ultraviolet Radiation-induced DNA Damage in Healthy Volunteers

Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers

United Kingdom
Institute of Child Health

Completed

The Effect of Caudal Volumes on the Anatomical Spread of Caudals in Children

Asa 1 and 2 Patients for Elective Surgery Requiring Caudal as Part of Their Care

United Kingdom
Clavis Pharma

Completed

Elacytarabine Mass Balance Study in Healthy Volunteers

Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects

United Kingdom
Newtricious R&D BV
Sprim Advanced Life Sciences

Completed

Intervention Trial in Early Age-related Macular Degeneration (I-TEAM)

Age-related Macular Degeneration (AMD)

United States, Germany, Netherlands, United Kingdom
H Scott Boswell
Takeda

Terminated

Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib

AML | AML, Adult

United States
Astellas Pharma Global Development, Inc.

Recruiting

A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)

United States, Canada, Germany, Italy, Spain, United Kingdom, France
University of Birmingham

Completed

A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) (PARC)

Cancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AML

United Kingdom, Australia, Netherlands
Astellas Pharma Global Development, Inc.

Completed

A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation

United States
Moorfields Eye Hospital NHS Foundation Trust

Completed

Dual Wavelength OCT

Retinal Degeneration | Diabetic Retinopathy | Retinal Dystrophies | AMD

United Kingdom
Manchester University NHS Foundation Trust

Recruiting

Shoulder Surgery Traditional vs Accelerated Rehabilitation Trial (S-START)

Rotator Cuff Tear | Rotator Cuff Tear or Rupture, Not Specified as Traumatic

United Kingdom
Etan Orgel
Astellas Pharma Global Development, Inc.

No longer available

Individual Patient Expanded Access Gilteritinib (ASP2215)

AML

United States
University Hospitals, Leicester

Completed

Abdominal Plane Blocks (APB) in Chronic Abdominal Pain (CAP)

Abdominal Pain | Abdominal Myofascial Pain Syndrome (AMPS) | Abdominal Plane Blocks (APB)

United Kingdom
Beth Israel Deaconess Medical Center
National Institute of Neurological Disorders and Stroke (NINDS); Dartmouth-Hitchcock...

Completed

Feasibility of an Electrical Impedance Tomography Device for Pulmonary Function Testing in ALS Patients

ALS

United States
Research Foundation for Mental Hygiene, Inc.
Columbia University

Withdrawn

Coping Effectiveness Training for ALS

Distress | ALS

United States
CHRISTUS Health

Completed

Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness (PAMS)

Acute Mountain Sickness | AMS

United States
University of Pennsylvania
University of Miami; Biogen; University of Kansas

Terminated

Multimodal Imaging Outcome Measures for ALS (Image ALS)

ALS

United States
University of Pittsburgh
ALS Association

Completed

Optimizing NIPPV Use for Patients With ALS

ALS

United States
Alcon Research

Completed

Anecortave Acetate Versus Placebo in AMD Patients Following PDT

AMD

United States
Weill Medical College of Cornell University

Completed

Safety of Caprylic Triglycerides in ALS: A Pilot Study

ALS

United States
Cell Medica Ltd
University College, London; Cell Therapy Catapult

Completed

A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients

Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)

United Kingdom, Germany, Belgium
Montefiore Medical Center

Recruiting

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

AML | MDS

United States
Alcon Research

Terminated

Anecortave Acetate Risk-Reduction Trial (AART)

Dry AMD

United States
University of Nottingham

Unknown

Immune Function in Patients With Obstructive Jaundice

Obstructive Jaundice | Immune Tolerance | Disease as Reason for ERCP | Immune Dysfunction

United Kingdom
Omar Jawdat
Rare Diseases Clinical Research Network; Terra Biological LLC; Clinical Research...

Unknown

Trial of Oxaloacetate in ALS (TOALS)

ALS

United States
Duke University

Completed

Respiratory Muscle Training (RMT) in ALS

ALS

United States
VisionCare, Inc.

Recruiting

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

Age-Related Macular Degeneration | AMD

Italy, Ireland, Spain, Germany, United Kingdom
Oraya Therapeutics, Inc.

Completed

INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD (INTREPID)

Eye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | AMD | Wet AMD | Wet Age-Related Macular Degeneration

United Kingdom, Czech Republic, Austria, Germany, Italy
Astellas Pharma Global Development, Inc.

Active, not recruiting

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation

United States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
Trio Medicines Ltd.
Biogen

Completed

Avonex®: Safety, Blood Levels and Effects (C-851)

Multiple Sclerosis (MS)

United Kingdom
M.D. Anderson Cancer Center

Recruiting

A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure

AML | MDS

United States
Retina Institute of Hawaii

Completed

Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis

Wet AMD

United States
Abramson Cancer Center at Penn Medicine
Bristol-Myers Squibb

Recruiting

Assessment of Geriatric Evaluations Impact on New AML Guidance (AGE-ING)

AML, Adult

United States
East Kent Hospitals University NHS Foundation Trust

Completed

Robotics for Mobility Rehabilitation in MS (RAPPERIII)

Multiple Sclerosis | MS

United Kingdom
Pfizer

Terminated

A Study Of Early Markers Of Choroidal Neovascularization

Age-related Macular Degeneration (AMD) | Choroidal Neovascularization (CNV) | Early Markers

Italy, Portugal, United Kingdom
University of Liverpool
St Helens & Knowsley Teaching Hospitals NHS Trust

Not yet recruiting

Differing Completion Rates of DIABETES Education on Patient Reported Outcomes (DIABETES-PRO)

Diabetes Mellitus, Type 2 | Patient Education as Topic

United Kingdom
Liverpool Heart and Chest Hospital NHS Foundation...
University of Liverpool

Withdrawn

Early Detection of Surgical Wound Infections Using Sensor Technology (SSI-Sensor)

Surgical Wound Infection | Heart; Surgery, Heart, Functional Disturbance as Result

United Kingdom
David Iberri

Terminated

Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults | AML (Adult) With 11q23 (MLL) Abnormalities | AML (Adult) With Del (5q) | AML (Adult) With Inv (16) (p13; q22) | AML (Adult) With t (16;16) (p13; q22) | AML (Adult) With t (8; 21) (q22; q22) and other conditions

United States
Sheffield Teaching Hospitals NHS Foundation Trust

Unknown

A Programme for Amyotrophic Lateral Sclerosis Care in Europe (ALS-CarE)

ALS (Amyotrophic Lateral Sclerosis) | MND (Motor Neurone DIsease)

United Kingdom
PhenoSolve, LLC
Jacobi Medical Center; Boston Clinical Trials

Completed

Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD

ADHD | PMS

United States
Milton S. Hershey Medical Center
BioSensics

Recruiting

Digital Tools for Assessment of Motor Functions and Falls in ALS

ALS | PLS | PMA

United States
St. Louis University

Completed

Text4Peds: Short Message Service Evaluating Medical Student Education

SMS | Education, Medical, Undergraduate

United States

Clinical Trials on AMS in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations